| CATEGORY: SMALL CAPS NEWS SECTOR: PHARMACEUTICALS & BIOTECHNOLOGY |
Phosphagenics starts trials on cancer drug |
|
Tue 24 Jan 2006
|
LONDON (SHARECAST) - Pharmaceutical group Phosphagenics revealed that it will initiate animal trials later this month on its patented anti-cancer compound GTP-0805.
It comes after positive findings from laboratory studies on the compound, conducted in prostate and breast cancer cells on behalf of the group by cancer research firm Malaysian Palm Oil Board.
Studies showed the compound induced a greater than 90% reduction in breast and prostate cancer cells.
"We are particularly delighted with our initial test results because they suggest GTP-0805 has a unique action that selectively inhibits and destroys cancer cells while leaving healthy cells undamaged," said executive director of research and development at Phosphagenics Esra Ogru.
"We look forward to developing it further and hope to begin clinical trials by the end of the year," he added.
|
|
| |
|
 |
Front Page Stories |
 |
|
